ISOXAZOLINE DERIVATIVES AS INSECTICIDAL COMPOUNDS
    7.
    发明公开
    ISOXAZOLINE DERIVATIVES AS INSECTICIDAL COMPOUNDS 有权
    异恶唑啉衍生物作为杀虫化合物

    公开(公告)号:EP2748155A1

    公开(公告)日:2014-07-02

    申请号:EP12748717.1

    申请日:2012-08-24

    摘要: The present invention provides compounds of formula (I), wherein G
    1 is oxygen; R
    1 is hydrogen; R
    2 is group P (P) L is a bond, methylene or ethylene; one of A
    1 and A
    2 is S, SO or SO
    2 and the other is -C(R
    4 )R
    4 -R
    3 is hydrogen or methyl; each R
    4 is independently hydrogen or methyl; Y
    1 is C-R
    6 , CH or nitrogen; Y
    2 and Y
    3 are independently CH or nitrogen; wherein no more than two of Y
    1 , Y
    2 and Y
    3 are nitrogen and wherein Y
    2 and Y
    3 are not both nitrogen; R
    5 is hydrogen, halogen, cyano, nitro, NH
    2 , C
    1 -C
    2 alkyl, C
    1 -C
    2 haloalkyl, C
    3 -C
    5 cycloalkyl, C
    3 -C
    5 halocycloalkyl, C
    1 -C
    2 alkoxy, C
    1 -C
    2 haloalkoxy; R
    6 together with R
    5 forms a -CH=CH-CH=CH- bridge; X
    2 is C-X
    6 or nitrogen; X
    1 , X
    3 and X
    6 are independently hydrogen, halogen or trihalomethyl, wherein at least two of X
    1 , X
    3 and X
    6 are not hydrogen; X
    4 is trifluoromethyl, difluoromethyl or chlorodifluoromethyl. The invention also provides intermediates useful for the preparation of compounds of formula (I), as well as methods of controlling insects, acarines, nematodes or molluscs using the compounds of formula (I).

    摘要翻译: 本发明提供了式(I)的化合物,其中G 1是氧; R 1是氢; R 2是基团P(P)L是键,亚甲基或亚乙基; A 1和A 2中的一个是S,SO或SO 2,另一个是-C(R 4)R 4 -R 3是氢或甲基; 每个R 4独立地为氢或甲基; Y 1是C-R 6,CH或氮; Y 2和Y 3独立地为CH或氮; 其中Y 1,Y 2和Y 3中不多于两个是氮,并且其中Y 2和Y 3不都是氮; 卤素,氰基,硝基,NH 2,C 1 -C 2烷基,C 1 -C 2卤代烷基,C 3 -C 5环烷基,C 3 -C 5卤代环烷基,C 1 -C 2烷氧基,C 1 -C 2卤代烷氧基; R 6与R 5一起形成-CH = CH-CH = CH-桥; X 2是C-X 6或氮; X 1,X 3和X 6独立地为氢,卤素或三卤代甲基,其中X 1,X 3和X 6中的至少两个不是氢; X 4是三氟甲基,二氟甲基或氯二氟甲基。 本发明还提供可用于制备式(I)化合物的中间体,以及使用式(I)化合物防治昆虫,螨,线虫或软体动物的方法。

    TYROSINE KINASE INHIBITORS
    10.
    发明公开
    TYROSINE KINASE INHIBITORS 审中-公开
    酪氨酸激酶抑制剂

    公开(公告)号:EP1951047A2

    公开(公告)日:2008-08-06

    申请号:EP06826158.5

    申请日:2006-10-18

    申请人: Merck & Co., Inc.

    摘要: The present invention relates to imidazo[1,2-a]pyrimidine derivatives, that are useful for treating cellular proliferative diseases, for treating disorders associated with MET activity, and for inhibiting the receptor tyrosine kinase MET. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.

    摘要翻译: 本发明涉及咪唑并[1,2-a]嘧啶衍生物,其用于治疗细胞增殖性疾病,用于治疗与MET活性相关的病症,以及用于抑制受体酪氨酸激酶MET。 本发明还涉及包含这些化合物的组合物,以及使用它们治疗哺乳动物癌症的方法。